vemurafenib
Yi palo
This template is part of the ArticlePlaceholder extension. If you want to adjust it, please consider making your changes upstream.
chemical compound
buɣusi la
type of chemical entity
yaɣ sheli
chemical compound
Di bukaata
tima
tima yaɣa
timsim
489.073 dalton[3]
chemical formula
C₂₃H₁₈ClF₂N₃O₃S[3]
canonical SMILES
CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F[3]
active ingredient in
Zelboraf[24]
World Health Organisation international non-proprietary name
vemurafenib[2]
medical condition treated
hairy cell leukemia[25]
metastatic melanoma[25]
skin cancer[25]
Erdheim-Chester disease[25]
melanoma[25]
significant drug interaction
taba laɣim di fiila
pregnancy category
Australian pregnancy category D
US pregnancy category D
LiverTox likelihood score
LiverTox toxicity likelihood category E*[28]
bachikpani mali tuma
antineoplastic[29]
protein kinase inhibitors[30]
xenobiotic-transporting ATPase inhibitor[30]
enzyme inhibitor[29]
pubu Commons ni
Vemurafenib
Reference
- ↑ Freebase Data Dumps, 28 Silimin gɔli October 2013
- ↑ 2.0 2.1 2.2 2.3 2.4 ChEBI, 18 Silimin gɔli October 2016, Silmiinsili, vemurafenib, 63637
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 PubChem, 18 Silimin gɔli October 2016, Silmiinsili, 42611257, Vemurafenib
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 GPXBXXGIAQBQNI-UHFFFAOYSA-N, InChIKey
- ↑ 5.0 5.1 UniChem
- ↑ Quora
- ↑ Global Substance Registration System, 18 Silimin gɔli October 2016, Silmiinsili, vemurafenib, 207SMY3FQT
- ↑ DrugBank, Silmiinsili, 17 Silimin gɔli November 2015, 08881, Vemurafenib
- ↑ Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 3OG7, 3OG7
- ↑ Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 5HES, 5HES
- ↑ Protein Data Bank, 18 Silimin gɔli October 2016, Silmiinsili, 4RZV, 4RZV
- ↑ OpenAlex, 26 Silimin gɔli January 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
- ↑ ChEMBL, 18 Silimin gɔli October 2016, Silmiinsili, VEMURAFENIB, CHEMBL1229517
- ↑ BBC Things
- ↑ ChEBI release 2020-09-01
- ↑ inferred from InChIKey
- ↑ CAS Common Chemistry, 8 Silimin gɔli April 2021, https://commonchemistry.cas.org/detail?cas_rn=918504-65-1, GPXBXXGIAQBQNI-UHFFFAOYSA-N
- ↑ InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28), International Chemical Identifier
- ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 18 Silimin gɔli October 2016, Silmiinsili, 5893, vemurafenib
- ↑ Hazardous Substances Data Bank, 10 Silimin gɔli May 2021, 28 Silimin gɔli October 2019, Vemurafenib, 8143
- ↑ ChemSpider, 18 Silimin gɔli October 2016, Silmiinsili, 24747352, Vemurafenib
- ↑ NDF-RT, 19 Silimin gɔli January 2016, Silmiinsili, VEMURAFENIB, N0000183250
- ↑ Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
- ↑ RxNorm, 1147224, 14 Silimin gɔli February 2018
- ↑ 25.0 25.1 25.2 25.3 25.4 Drug Indications Extracted from FAERS, 2 Silimin gɔli October 2018
- ↑ 26.0 26.1 26.2 A reference set of clinically relevant adverse drug-drug interactions, hypothetically
- ↑ 27.0 27.1 IUPHAR/BPS Guide to PHARMACOLOGY, 17 Silimin gɔli August 2016, 5893, Silmiinsili
- ↑ LiverTox, 8 Silimin gɔli April 2021, https://www.ncbi.nlm.nih.gov/books/n/livertox/Vemurafenib, 28 Silimin gɔli June 2018
- ↑ 29.0 29.1 Medical Subject Headings, 15 Silimin gɔli March 2018, C551177
- ↑ 30.0 30.1 N0000183250, 5 Silimin gɔli March 2018, NDF-RT